262 related articles for article (PubMed ID: 33902190)
41. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Nikolopoulou G; Raptopoulou-Gigi M; Gogos C; Vafiadis-Zouboulis I; Karamanolis D; Chouta A; Ilias A; Drakoulis C; Mimidis K; Ketikoglou I; Manesis E; Mela M; Hatzis G; Dalekos GN;
J Viral Hepat; 2015 Feb; 22(2):120-7. PubMed ID: 25040685
[TBL] [Abstract][Full Text] [Related]
42. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
43. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
44. Effects of diary food supplements on bone mineral density in teenage girls.
Merrilees MJ; Smart EJ; Gilchrist NL; Frampton C; Turner JG; Hooke E; March RL; Maguire P
Eur J Nutr; 2000 Dec; 39(6):256-62. PubMed ID: 11395985
[TBL] [Abstract][Full Text] [Related]
45. Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis.
Kim MJ; Shim MS; Kim MK; Lee Y; Shin YG; Chung CH; Kwon SO
Korean J Intern Med; 2003 Sep; 18(3):174-80. PubMed ID: 14619387
[TBL] [Abstract][Full Text] [Related]
46. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
48. Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.
Li T; Qu Y; Wang Y; Lin C; Yang B; Wang L
J Coll Physicians Surg Pak; 2019 Apr; 29(4):317-323. PubMed ID: 30925952
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of bone mass and relevance ratio of osteoporosis among middle aged and elderly population in Beijing community].
Zhang YL; Wei X; Xie YM; Zhu LG; Gao JH; Shen H; Chai Y; Sun MH; Zhang C; Sun K; Tang B; Jiang JJ; Zhi YJ; Yu CC
Zhongguo Gu Shang; 2020 Oct; 33(10):916-21. PubMed ID: 33107253
[TBL] [Abstract][Full Text] [Related]
50. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.
Wong GL; Chan HL; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Lai JW; Lo AO; Chan HY; Wong VW
Hepatology; 2013 Nov; 58(5):1537-47. PubMed ID: 23389810
[TBL] [Abstract][Full Text] [Related]
51. Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B.
Cho YY; Chang Y; Nam JY; Cho H; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
Gut Liver; 2020 Mar; 14(2):225-231. PubMed ID: 31060115
[TBL] [Abstract][Full Text] [Related]
52. Distribution of Z-scores in a University cohort with an emphasis on "high" bone mineral density.
Morgan SL; Peace F; Lopez-Ben R; Fineberg N
J Clin Densitom; 2010; 13(4):385-91. PubMed ID: 21029974
[TBL] [Abstract][Full Text] [Related]
53. Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.
Saadah OI; Sindi HH; Bin-Talib Y; Al-Harthi S; Al-Mughales J
Arab J Gastroenterol; 2012 Jun; 13(2):41-4. PubMed ID: 22980589
[TBL] [Abstract][Full Text] [Related]
54. The prevalence of significant left-right differences in hip bone mineral density.
Hamdy R; Kiebzak GM; Seier E; Watts NB
Osteoporos Int; 2006 Dec; 17(12):1772-80. PubMed ID: 17019523
[TBL] [Abstract][Full Text] [Related]
55. Bone mineral density in healthy Dutch women: spine and hip measurements using dual-energy X-ray absorptiometry.
Erdtsieck RJ; Pols HA; Algra D; Kooy PP; Birkenhäger JC
Neth J Med; 1994 Nov; 45(5):198-205. PubMed ID: 7830845
[TBL] [Abstract][Full Text] [Related]
56. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
Trinh S; Le AK; Chang ET; Hoang J; Jeong D; Chung M; Lee MH; Wang U; Henry L; Cheung R; Nguyen MH
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):948-956.e1. PubMed ID: 30130625
[TBL] [Abstract][Full Text] [Related]
57. Factors associated with the lumbar spine and proximal femur bone mineral density in older men.
Cauley JA; Fullman RL; Stone KL; Zmuda JM; Bauer DC; Barrett-Connor E; Ensrud K; Lau EM; Orwoll ES;
Osteoporos Int; 2005 Dec; 16(12):1525-37. PubMed ID: 15889316
[TBL] [Abstract][Full Text] [Related]
58. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy.
Lin TC; Chiu YC; Chiu HC; Liu WC; Cheng PN; Chen CY; Chang TT; Wu IC
World J Gastroenterol; 2018 Feb; 24(6):725-736. PubMed ID: 29456411
[TBL] [Abstract][Full Text] [Related]
59. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
Di X; Li Y; Zhang C; Jiang J; Gu S
Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
[TBL] [Abstract][Full Text] [Related]
60. Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women According to Antiosteoporotic Medication Use.
Kim YU; Karm MH; Cheong Y; Lee J; Kong YG; Kim SH; Suh JH
Pain Physician; 2016 Jul; 19(6):389-96. PubMed ID: 27454269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
